approval

The long wait for an XRP Exchange-Traded Fund (ETF) just got more serious. The U.S. Securities and Exchange Commission (SEC) has officially started a formal process to decide whether to approve or reject the proposed Franklin XRP ETF.  A final decision is expected by September 9, 2025 — a date to watch out for. XRP

Lower activity levels and “widespread” Building Safety Act (BSA)-related delays are set to hit full-year turnover at Van Elle Holdings. In a trading update this morning, the firm – ranked by Construction News as the UK’s second-largest ground engineering specialist – said it expected revenue of £134m for the year to 30 April 2025. This

A popular crypto analyst from the Good Morning Crypto podcast has made a strong prediction about XRP. He believes that the approval of XRP-based ETFs could trigger massive buying pressure, pushing prices higher. According to him, once proper regulations are in place, both investors and daily users of XRP could find themselves racing to grab

Spain’s BBVA has received regulatory approval to offer Bitcoin (BTC) and Ether (ETH) trading, aligning with the EU’s MiCA regulations, according to Reuters. This marks the end of a multi-year effort to expand into digital assets. Initially, BBVA planned to launch crypto services in Switzerland due to its clear regulations. The bank also introduced crypto

Ever since the institutions have gauged the success of the spot Bitcoin & Ethereum ETF, they have intensified their search for other potential ETFs. While Solana has strengthened its base with zero network outrage in the past 12 months, XRP has proved to be a sleeping giant after the remarkable bull run. Now that both

The first Neuralink clinical trials outside the US will take place in Canada. Neuralink has secured Health Canada's approval to launch human trials in the country, with the Toronto Western Hospital being the "first and exclusive surgical site" for the procedure. The company first opened its Canadian patient registry in March this year, but now

Science & Nature This letter from SARA is to issue a waiver for NASA grantees attending the 2025 Lunar and Planetary Science Conference (LPSC),...

Special Reports > Features — Education about the availability and need for naloxone is critical, expert says by Michael DePeau-Wilson, Enterprise & Investigative Writer, MedPage Today March 31, 2023 This week's FDA approval of the first-ever over-the-counter (OTC) naloxone product (Narcan) for the treatment of opioid overdoses was broadly praised, but medical and industry experts